Routine

Peripheral neuropathy diagnostic work-up

Polyneuropathy evaluation · Neurology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

A structured approach to the patient with sensory, motor or autonomic symptoms of peripheral nerve dysfunction, aiming to define the pattern, identify treatable causes and avoid over-investigation. Most chronic length-dependent neuropathies have identifiable metabolic or toxic causes.

Red flags

  • Rapidly progressive or ascending weakness (consider GBS/CIDP)
  • Asymmetric or multifocal pattern (vasculitis, MMN)
  • Prominent autonomic failure
  • Weight loss or systemic features (paraneoplastic/vasculitic)
  • Early severe sensory ataxia (ganglionopathy)

Assessment

Differential diagnosis

  • Diabetic/metabolic length-dependent neuropathy
  • Alcohol or nutritional (B12, thiamine) neuropathy
  • Inflammatory neuropathy (CIDP, vasculitic)
  • Hereditary neuropathy (CMT)
  • Paraproteinaemic neuropathy
  • Drug/toxic neuropathy
  • Paraneoplastic/sensory ganglionopathy

Investigations

  • HbA1c/fasting glucose (and OGTT if impaired)
  • Vitamin B12, folate and full blood count
  • Thyroid function, renal and liver function
  • Serum protein electrophoresis and immunofixation
  • ESR/CRP, autoimmune screen if inflammatory suspected
  • Nerve conduction studies/EMG to classify axonal vs demyelinating and distribution
  • Genetic testing or further tests (anti-MAG, paraneoplastic) guided by pattern

Management

  • Characterise the neuropathy by fibre type, distribution and time course
  • Distinguish length-dependent symmetrical from asymmetric/multifocal patterns (the latter suggest treatable causes)
  • Take a thorough drug, alcohol, occupational and family history
  • Order first-line screening bloods for common metabolic causes
  • Use nerve conduction studies to classify axonal versus demyelinating
  • Pursue demyelinating or asymmetric/rapidly progressive neuropathies aggressively (treatable)
  • Add second-line tests (paraprotein work-up, genetics, paraneoplastic) guided by pattern
  • Treat the underlying cause where found
  • Manage neuropathic pain symptomatically
  • Provide foot care, falls prevention and reassurance for idiopathic cases

Drugs & doses

Treat cause-specific (e.g. B12 replacement, glycaemic control)
Amitriptyline 10-75 mg PO nocte for neuropathic pain
Duloxetine 30-60 mg PO daily
Gabapentin 300 mg PO TDS titrated or pregabalin 75-300 mg PO BD
Replace thiamine/B12 where deficient

Disposition

Primary care or outpatient neurology. Urgent referral for rapidly progressive, asymmetric or demyelinating neuropathy.

Complications & pitfalls

  • Foot ulceration and Charcot joints
  • Falls and injury
  • Missed treatable cause
  • Chronic neuropathic pain
  • Autonomic instability

Exam pearls

  • Asymmetric, rapidly progressive or demyelinating neuropathies are the treatable ones; investigate them hard
  • A simple metabolic screen identifies most causes of chronic axonal neuropathy
  • Up to a quarter remain idiopathic after full work-up; avoid endless testing
  • Always ask about alcohol, drugs and family history

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.